{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:54:07Z","timestamp":1794020047420,"version":"4.8.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100011666","name":"Ehlers-Danlos Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011666","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1186\/s12014-026-09588-2","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T05:15:25Z","timestamp":1772860525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proximity extension assay-based serum proteomic profiling identifies shared protein signatures in hypermobile Ehlers\u2013Danlos syndrome and hypermobility spectrum disorders"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1545-4801","authenticated-orcid":false,"given":"Valeria","family":"Cinquina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8096-9417","authenticated-orcid":false,"given":"Giulia","family":"Carini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1760-5079","authenticated-orcid":false,"given":"Nicola","family":"Chiarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0424-4235","authenticated-orcid":false,"given":"Marika","family":"Vezzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9199-1872","authenticated-orcid":false,"given":"Valeria","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6800-3695","authenticated-orcid":false,"given":"Marina","family":"Venturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woodrow","family":"Gandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3105-5990","authenticated-orcid":false,"given":"Marina","family":"Colombi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7025-2495","authenticated-orcid":false,"given":"Marco","family":"Ritelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"9588_CR1","doi-asserted-by":"publisher","unstructured":"Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H et al. Hypermobile Ehlers\u2013Danlos syndrome (a.k.a. Ehlers\u2013Danlos syndrome Type III and Ehlers\u2013Danlos syndrome hypermobility type): Clinical description and natural history. Am J Med Genet C Semin Med Genet. 2017r;175(1):48-69. https:\/\/doi.org\/10.1002\/ajmg.c.31538","DOI":"10.1002\/ajmg.c.31538"},{"key":"9588_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ajmg.c.31552","volume":"175","author":"F Malfait","year":"2017","unstructured":"Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, et al. The 2017 international classification of the Ehlers\u2013Danlos syndromes.Am J Med Genet C Semin Med Genet. 2017;175(1):8-26. http:\/\/doi.org\/10.1002\/ajmg.c.31552.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"9588_CR3","doi-asserted-by":"publisher","unstructured":"Malfait F, Castori M, Francomano CA, Giunta C, Kosho T, Byers PH. The Ehlers\u2013Danlos syndromes.Nat Rev Dis Primers. 2020;6(1):64. https:\/\/doi.org\/10.1038\/s41572-020-0194-9","DOI":"10.1038\/s41572-020-0194-9"},{"key":"9588_CR4","doi-asserted-by":"publisher","unstructured":"Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A. A framework for the classification of joint hypermobility and related conditions. Am J Med Genet C Semin Med Genet. 2017;175(1):148-157. https:\/\/doi.org\/10.1002\/ajmg.c.31539","DOI":"10.1002\/ajmg.c.31539"},{"key":"9588_CR5","doi-asserted-by":"publisher","unstructured":"Gensemer C, Burks R, Kautz S, Judge DP, Lavallee M, Norris RA. Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes. Dev Dyn. 2021 ;250(3):318-344. https:\/\/doi.org\/10.1002\/dvdy.220","DOI":"10.1002\/dvdy.220"},{"key":"9588_CR6","doi-asserted-by":"publisher","unstructured":"Carroll MB. Hypermobility spectrum disorders: A review.]Rheumatol Immunol Res. 2023;22;4(2):60-68. https:\/\/doi.org\/10.2478\/rir-2023-0010","DOI":"10.2478\/rir-2023-0010"},{"key":"9588_CR7","doi-asserted-by":"publisher","unstructured":"Ritelli M, Chiarelli N, Cinquina V, Vezzoli M, Venturini M, Colombi M. Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference centerAm J Med Genet A. 2024;194(2):174-194. https:\/\/doi.org\/10.1002\/ajmg.a.63426","DOI":"10.1002\/ajmg.a.63426"},{"key":"9588_CR8","doi-asserted-by":"publisher","unstructured":"Chiarelli N, Zoppi N, Ritelli M, Venturini M, Capitanio D, Gelfi C et al. Biological insights in the pathogenesis of hypermobile Ehlers-Danlos syndrome from proteome profiling of patients\u2019 dermal myofibroblasts. Biochim Biophys Acta Mol Basis Dis. 2021;1867(4):166051. https:\/\/doi.org\/10.1016\/j.bbadis.2020.166051","DOI":"10.1016\/j.bbadis.2020.166051"},{"key":"9588_CR9","doi-asserted-by":"publisher","unstructured":"Chiarelli N, Zoppi N, Venturini M, Capitanio D, Gelfi C, Ritelli M et al. Matrix metalloproteinases inhibition by doxycycline rescues extracellular matrix organization and partly reverts myofibroblast differentiation in hypermobile ehlers-danlos syndrome dermal fibroblasts: A potential therapeutic target? Cells. 2021;10(11):3236. https:\/\/doi.org\/10.3390\/cells10113236","DOI":"10.3390\/cells10113236"},{"key":"9588_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63857","author":"M Ritelli","year":"2025","unstructured":"Ritelli M, Chiarelli N, Cinquina V, Bertini V, Piantoni S, Caproli A, et al. Bridging the diagnostic gap for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: evidence of a common extracellular matrix fragmentation pattern in patient plasma as a potential biomarker. Am J Med Genet A. 2025. https:\/\/doi.org\/10.1002\/ajmg.a.63857.","journal-title":"Am J Med Genet A"},{"key":"9588_CR11","doi-asserted-by":"publisher","unstructured":"Ritelli M, Chiarelli N, Cinquina V, Zoppi N, Bertini V, Venturini M et al. RNA-Seq of Dermal Fibroblasts from Patients with Hypermobile Ehlers\u2013Danlos Syndrome and Hypermobility Spectrum Disorders Supports Their Categorization as a Single Entity with Involvement of Extracellular Matrix Degrading and Proinflammatory Pathomechanism. Cells2022;11(24):4040. https:\/\/doi.org\/10.3390\/cells11244040","DOI":"10.3390\/cells11244040"},{"key":"9588_CR12","doi-asserted-by":"publisher","unstructured":"Demmler JC, Atkinson MD, Reinhold EJ, Choy E, Lyons RA, Brophy ST. Diagnosed prevalence of Ehlers-Danlos syndrome and hypermobility spectrum disorder in Wales, UK: a national electronic cohort study and case-control comparison. BMJ Open. 2019;9(11):e031365. https:\/\/doi.org\/10.1136\/bmjopen-2019-031365","DOI":"10.1136\/bmjopen-2019-031365"},{"key":"9588_CR13","doi-asserted-by":"publisher","unstructured":"Hakim AJ, Tinkle BT, Francomano CA. Ehlers\u2013Danlos syndromes, hypermobility spectrum disorders, and associated co-morbidities: Reports from EDS ECHO. Am J Med Genet C Semin Med Genet. 2021;187(4):413-415. https:\/\/doi.org\/10.1002\/ajmg.c.31954","DOI":"10.1002\/ajmg.c.31954"},{"key":"9588_CR14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ajmg.c.31935","volume":"187","author":"CME Halverson","year":"2021","unstructured":"Halverson CME, Clayton EW, Garcia Sierra A, Francomano C. Patients with Ehlers\u2013Danlos syndrome on the diagnostic odyssey: rethinking complexity and difficulty as a hero\u2019s journey. Am J Med Genet C Semin Med Genet. 2021;187:416\u201324. http:\/\/doi.orh\/10.1002\/ajmg.c.31935.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"9588_CR15","doi-asserted-by":"publisher","unstructured":"Daylor V, Griggs M, Weintraub A, Byrd R, Petrucci T, Huff M et al. Defining the Clinical Complexity of hEDS and HSD: A Global Survey of Diagnostic Challenge, Comorbidities, and Unmet Needs.J Clin Med. 2025;14(16):5636. https:\/\/doi.org\/10.3390\/jcm14165636","DOI":"10.3390\/jcm14165636"},{"key":"9588_CR16","doi-asserted-by":"publisher","unstructured":"Wang YT, Jahani S, Morel-Swols D, Kapely A, Rosen A, Forghani I. Patient experiences of receiving a diagnosis of hypermobile Ehlers\u2013Danlos syndrome. Am J Med Genet Part A. 2024;194(8):e63613. https:\/\/doi.org\/10.1002\/ajmg.a.63613","DOI":"10.1002\/ajmg.a.63613"},{"key":"9588_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/children12060698","volume":"12","author":"C Lee","year":"2025","unstructured":"Lee C, Chopra P. The incidence of misdiagnosis in patients with Ehlers\u2013Danlos syndrome. Children (Basel). 2025;12:698. https:\/\/doi.org\/10.3390\/children12060698.","journal-title":"Children"},{"key":"9588_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/JXX.0000000000000672","author":"LK Anderson","year":"2022","unstructured":"Anderson LK, Lane KR. The diagnostic journey in adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. J Am Assoc Nurse Pract. 2022. https:\/\/doi.org\/10.1097\/JXX.0000000000000672.","journal-title":"J. Am. Assoc. Nurse Pract"},{"key":"9588_CR19","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1007\/s00296-024-05676-4","volume":"44","author":"WR Black","year":"2024","unstructured":"Black WR, Black LL, Goldstein-Leever A, Fox LS, Pratt LR, Jones JT. The need for primary care providers in the clinical management of hypermobility spectrum disorders and ehlers-danlos syndrome: a call to action. Rheumatol Int. 2024;44:2273\u20138. https:\/\/doi.org\/10.1007\/s00296-024-05676-4","journal-title":"Rheumatol Int"},{"key":"9588_CR20","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2021.04.200374","author":"K Atwell","year":"2021","unstructured":"Atwell K, Michael W, Dubey J, James S, Martonffy A, Anderson S, et al. Diagnosis and management of hypermobility spectrum disorders in primary care. J Am Board Fam Med. 2021. https:\/\/doi.org\/10.3122\/jabfm.2021.04.200374.","journal-title":"J Am Board Fam Med"},{"key":"9588_CR21","doi-asserted-by":"publisher","unstructured":"Zoppi N, Chiarelli N, Binetti S, Ritelli M, Colombi M. Dermal fibroblast-to-myofibroblast transition sustained by \u03b1v\u00df3 integrin-ILK-Snail1\/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Biochim Biophys Acta Mol Basis Dis. 2018;1864(4 Pt A):1010-1023. https:\/\/doi.org\/10.1016\/j.bbadis.2018.01.005","DOI":"10.1016\/j.bbadis.2018.01.005"},{"key":"9588_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/immhor\/vlaf044","author":"M Griggs","year":"2025","unstructured":"Griggs M, Daylor V, Petrucci T, Weintraub A, Huff M, Willey S, et al. Proteomic discoveries in hypermobile Ehlers\u2013Danlos syndrome reveal insights into disease pathophysiology. ImmunoHorizons. 2025. https:\/\/doi.org\/10.1093\/immhor\/vlaf044.","journal-title":"ImmunoHorizons"},{"key":"9588_CR23","doi-asserted-by":"publisher","unstructured":"Watanabe A, Satoh K, Maniwa T, Matsumoto KI. Proteomic analysis for the identification of serum diagnostic markers for joint hypermobility syndrome. Int J Mol Med. 2016;37(2):461-7. https:\/\/doi.org\/10.3892\/ijmm.2015.2437","DOI":"10.3892\/ijmm.2015.2437"},{"key":"9588_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr424","volume":"39","author":"M Lundberg","year":"2011","unstructured":"Lundberg M, Eriksson A, Tran B, Assarsson E, Fredriksson S. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res. 2011;39:e102. https:\/\/doi.org\/10.1093\/nar\/gkr424.","journal-title":"Nucleic Acids Res"},{"key":"9588_CR25","doi-asserted-by":"publisher","unstructured":"Hakim AJ, Grahame R. A simple questionnaire to detect hypermobility: An adjunct to the assessment of patients with diffuse musculoskeletal pain. Int J Clin Pract. 2003;57(3):163-6 https:\/\/doi.org\/10.1111\/j.1742-1241.2003.tb10455.x","DOI":"10.1111\/j.1742-1241.2003.tb10455.x"},{"key":"9588_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc Ser B Methodol. 1996;58:267\u201388.https:\/\/doi.org\/10.1111\/j.1467-9868.2011.00771.x","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"9588_CR27","doi-asserted-by":"publisher","unstructured":"Stekhoven DJ, B\u00fchlmann P. Missforest-Non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28(1):112-8. https:\/\/doi.org\/10.1093\/bioinformatics\/btr597","DOI":"10.1093\/bioinformatics\/btr597"},{"key":"9588_CR28","doi-asserted-by":"publisher","unstructured":"Vezzoli M, Inciardi RM, Oriecuia C, Paris S, Murillo NH, Agostoni P et al. Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: Results from an Italian multicenter study. J Cardiovasc Med (Hagerstown). 2022;23(7):439-446. https:\/\/doi.org\/10.2459\/JCM.0000000000001329","DOI":"10.2459\/JCM.0000000000001329"},{"key":"9588_CR29","doi-asserted-by":"publisher","unstructured":"Breiman, L. Random Forests. Machine Learning. 2001;45:5\u201332. https:\/\/doi.org\/10.1023\/A:1010933404324","DOI":"10.1023\/A:1010933404324"},{"key":"9588_CR30","doi-asserted-by":"publisher","unstructured":"Micheletti S, Galli J, Vezzoli M, Scaglioni V, Agostini S, Calza S et al. Academic skills in children with cerebral palsy and specific learning disorders. Dev Med Child Neurol. 2024;66(6):778-792. https:\/\/doi.org\/10.1111\/dmcn.15808","DOI":"10.1111\/dmcn.15808"},{"key":"9588_CR31","doi-asserted-by":"publisher","unstructured":"Doglietto F, Vezzoli M, Gheza F, Lussardi GL, Domenicucci M, Vecchiarelli L et al. Factors Associated with Surgical Mortality and Complications among Patients with and without Coronavirus Disease 2019 (COVID-19) in Italy. JAMA Surg. 2020;155(8):691-702. https:\/\/doi.org\/10.1001\/jamasurg.2020.2713","DOI":"10.1001\/jamasurg.2020.2713"},{"key":"9588_CR32","doi-asserted-by":"publisher","unstructured":"Vezzoli M. Exploring the facets of overall job satisfaction through a novel ensemble learning. Electron J Appld Statl Anal. 2011;4:23-38. https:\/\/doi.org\/10.1285\/I20705948V4N1P23","DOI":"10.1285\/I20705948V4N1P23"},{"key":"9588_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1285\/i20705948v5n1p89","volume":"5","author":"M Carpita","year":"2012","unstructured":"Carpita M, Vezzoli M. Statistical evidence of the subjective work quality: the fairness drivers of the job satisfaction. Electron J Appl Stat Anal. 2012;5:89\u2013107. https:\/\/doi.org\/10.1285\/i20705948v5n1p89","journal-title":"Electron J Appl Stat Anal"},{"key":"9588_CR34","doi-asserted-by":"publisher","unstructured":"Garrafa E, Segala A, Vezzoli M, Bottani E, Zanini B, Vetturi A et al. Mitochondrial Dysfunction in Peripheral Blood Mononuclear Cells as Novel Diagnostic Tools for Non-Alcoholic Fatty Liver Disease: Visualizing Relationships with Known and Potential Disease Biomarkers. Diagnostics (Basel). 2023;13(14):2363. https:\/\/doi.org\/10.3390\/diagnostics13142363","DOI":"10.3390\/diagnostics13142363"},{"key":"9588_CR35","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1214\/aos\/1013203451","volume":"29","author":"JH Friedman","year":"2001","unstructured":"Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Stat. 2001;29:1189\u2013232. https:\/\/doi.org\/10.1214\/aos\/1013203451","journal-title":"Ann Stat"},{"key":"9588_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2:100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141.","journal-title":"Innovation (Camb)"},{"key":"9588_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161347","author":"N Chiarelli","year":"2016","unstructured":"Chiarelli N, Carini G, Zoppi N, Dordoni C, Ritelli M, Venturini M, et al. Transcriptome-wide expression profiling in skin fibroblasts of patients with joint hypermobility syndrome\/ehlers-danlos syndrome hypermobility type. PLoS One. 2016. https:\/\/doi.org\/10.1371\/journal.pone.0161347.","journal-title":"PLoS One"},{"key":"9588_CR38","doi-asserted-by":"publisher","unstructured":"Martin A. An acquired or heritable connective tissue disorder? A review of hypermobile Ehlers Danlos Syndrome. Eur J Med Genet. 2019;62(7):103672. https:\/\/doi.org\/10.1016\/j.ejmg.2019.103672","DOI":"10.1016\/j.ejmg.2019.103672"},{"key":"9588_CR39","doi-asserted-by":"publisher","unstructured":"Alsiri N, Alhadhoud M, Alkatefi T, Palmer S. The concomitant diagnosis of fibromyalgia and connective tissue disorders: A systematic review.emin Arthritis Rheum. 2023;58:152127 https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152127","DOI":"10.1016\/j.semarthrit.2022.152127"},{"key":"9588_CR40","doi-asserted-by":"publisher","unstructured":"Wasim S, Suddaby JS, Parikh M, Leylachian S, Ho B, Guerin A et al. Pain and gastrointestinal dysfunction are significant associations with psychiatric disorders in patients with Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective study. Rheumatol Int. 2019;39(7):1241-1248. https:\/\/doi.org\/10.1007\/s00296-019-04293-w","DOI":"10.1007\/s00296-019-04293-w"},{"key":"9588_CR41","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/joim.13539","volume":"292","author":"A Fernandez","year":"2022","unstructured":"Fernandez A, Aubry-Rozier B, Vautey M, Berna C, Suter MR. Small fiber neuropathy in hypermobile Ehlers Danlos syndrome\/hypermobility spectrum disorder. J Intern Med. 2022;292(6):957-960. https:\/\/doi.org\/10.1111\/joim.13539","journal-title":"J Intern Med [Internet]"},{"key":"9588_CR42","doi-asserted-by":"publisher","unstructured":"Aubry-Rozier B, Schwitzguebel A, Valerio F, Tanniger J, Paquier C, Berna C et al. Are patients with hypermobile Ehlers\u2013Danlos syndrome or hypermobility spectrum disorder so different? Rheumatol Int. 2021;41(10):1785-1794 https:\/\/doi.org\/10.1007\/s00296-021-04968-3","DOI":"10.1007\/s00296-021-04968-3"},{"key":"9588_CR43","doi-asserted-by":"publisher","unstructured":"Rodgers KR, Gui J, Dinulos MBP, Chou RC. Ehlers-Danlos syndrome hypermobility type is associated with rheumatic diseases.Sci Rep. 2017;7:39636. https:\/\/doi.org\/10.1038\/srep39636","DOI":"10.1038\/srep39636"},{"key":"9588_CR44","doi-asserted-by":"publisher","unstructured":"Monaco A, Choi D, Uzun S, Maitland A, Riley B. Association of mast-cell-related conditions with hypermobile syndromes: a review of the literature. Immunol Res. 2022;70(4):419-431. https:\/\/doi.org\/10.1007\/s12026-022-09280-1","DOI":"10.1007\/s12026-022-09280-1"},{"key":"9588_CR45","doi-asserted-by":"publisher","unstructured":"Vazquez M, Chovanec J, Kim J, DiMaggio T, Milner JD, Francomano CA et al. Hereditary alpha-tryptasemia modifies clinical phenotypes among individuals with congenital hypermobility disorders. HGG Adv. 2022;3(2):100094. https:\/\/doi.org\/10.1016\/j.xhgg.2022.100094","DOI":"10.1016\/j.xhgg.2022.100094"},{"key":"9588_CR46","doi-asserted-by":"publisher","unstructured":"Brock I, Prendergast W, Maitland A. Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers-Danlos syndrome\/hypermobility spectrum disorder. Am J Med Genet C Semin Med Genet. 2021;187(4):473-481. https:\/\/doi.org\/10.1002\/ajmg.c.31940","DOI":"10.1002\/ajmg.c.31940"},{"key":"9588_CR47","doi-asserted-by":"publisher","unstructured":"Afrin LB. Some cases of hypermobile Ehlers\u2013Danlos syndrome may be rooted in mast cell activation syndrome. Am J Med Genet C Semin Med Genet. 2021;187(4):466-472. https:\/\/doi.org\/10.1002\/ajmg.c.31944","DOI":"10.1002\/ajmg.c.31944"},{"key":"9588_CR48","doi-asserted-by":"publisher","unstructured":"Gutowski \u0141, Kanikowski S, Formanowicz D. Mast Cell Involvement in the Pathogenesis of Selected Musculoskeletal Diseases. Life (Basel). 2023;13(8):1690. https:\/\/doi.org\/10.3390\/life13081690","DOI":"10.3390\/life13081690"},{"key":"9588_CR49","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/14728222.2019.1656718","volume":"23","author":"JB Bilsborrow","year":"2019","unstructured":"Bilsborrow JB, Doherty E, Tilstam PV, Bucala R. Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus. Expert Opin Ther Targets. 2019;23(9):733-744. https:\/\/doi.org\/10.1080\/14728222.2019.1656718","journal-title":"Expert Opin Ther Targets [Internet]"},{"key":"9588_CR50","doi-asserted-by":"publisher","unstructured":"Grieb G, Merk M, Bernhagen J, Bucala R. Macrophage Migration Inhibitory Factor (MIF): A promising biomarker.Drug News Perspect. 2010;23(4):257-64. https:\/\/doi.org\/10.1358\/dnp.2010.23.4.1453629","DOI":"10.1358\/dnp.2010.23.4.1453629"},{"key":"9588_CR51","doi-asserted-by":"publisher","unstructured":"Ferhat M, Mangano K, Mirkina I, Mayer J, Rossmueller G, Schinagl A et al. The newly engineered monoclonal antibody ON104, targeting the oxidized Macrophage Migration Inhibitory Factor (oxMIF), ameliorates clinical and histopathological signs of collagen-induced arthritis.Eur J Pharmacol. 2023;956:175997. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175997","DOI":"10.1016\/j.ejphar.2023.175997"},{"key":"9588_CR52","doi-asserted-by":"publisher","unstructured":"Satterthwaite AB. TLR7 Signaling in Lupus B Cells: New Insights into Synergizing Factors and Downstream Signals. Curr Rheumatol Rep. 2021;23(11):80. https:\/\/doi.org\/10.1007\/s11926-021-01047-1","DOI":"10.1007\/s11926-021-01047-1"},{"key":"9588_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102453","volume":"111","author":"AM Gorabi","year":"2020","unstructured":"Gorabi AM, Hajighasemi S, Kiaie N, Gheibi Hayat SM, Jamialahmadi T, Johnston TP, et al. The pivotal role of CD69 in autoimmunity. J Autoimmun. 2020;111:102453. https:\/\/doi.org\/10.1016\/j.jaut.2020.102453","journal-title":"J Autoimmun"},{"key":"9588_CR54","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez-Amaro R, Cort\u00e9s JR, S\u00e1nchez-Madrid F, Mart\u00edn P. Is CD69 an effective brake to control inflammatory diseases?Trends Mol Med. 2013;19(10):625-32. https:\/\/doi.org\/10.1016\/j.molmed.2013.07.006","DOI":"10.1016\/j.molmed.2013.07.006"},{"key":"9588_CR55","doi-asserted-by":"publisher","unstructured":"Vitales-Noyola M, Oceguera-Maldonado B, Ni\u00f1o-Moreno P, Baltazar-Ben\u00edtez N, Baranda L, Layseca-Espinosa E et al. Patients with Systemic Lupus Erythematosus Show Increased Levels and Defective Function of CD69\u2009+\u2009T Regulatory Cells. Mediators Inflamm. 2017;2017:2513829. https:\/\/doi.org\/10.1155\/2017\/2513829","DOI":"10.1155\/2017\/2513829"},{"key":"9588_CR56","doi-asserted-by":"publisher","unstructured":"Mishra CB, Tiwari M, Supuran CT. Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today? Med Res Rev. 2020;40(6):2485-2565. https:\/\/doi.org\/10.1002\/med.21713","DOI":"10.1002\/med.21713"},{"key":"9588_CR57","doi-asserted-by":"publisher","unstructured":"Supuran CT. Carbonic anhydrase inhibition and the management of neuropathic pain. Expert Rev Neurother. 2016;16(8):961-8. https:\/\/doi.org\/10.1080\/14737175.2016.1193009","DOI":"10.1080\/14737175.2016.1193009"},{"key":"9588_CR58","doi-asserted-by":"publisher","unstructured":"Micheli L, Bozdag M, Akgul O, Carta F, Guccione C, Bergonzi MC et al. Pain relieving effect of-NSAIDS-CAIs hybrid molecules: Systemic and intra-articular treatments against rheumatoid arthritis. Int J Mol Sci. 2019;20(8):1923. https:\/\/doi.org\/10.3390\/ijms20081923","DOI":"10.3390\/ijms20081923"},{"key":"9588_CR59","doi-asserted-by":"publisher","unstructured":"Zheng Y, Wang L, Zhang W, Xu H, Chang X. Transgenic mice over-expressing carbonic anhydrase i showed aggravated joint inflammation and tissue destruction.Musculoskelet Disord. 2012;13:256. https:\/\/doi.org\/10.1186\/1471-2474-13-256","DOI":"10.1186\/1471-2474-13-256"},{"key":"9588_CR60","doi-asserted-by":"publisher","unstructured":"Bua S, Di Cesare Mannelli L, Vullo D, Ghelardini C, Bartolucci G, Scozzafava A et al. Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis.J Med Chem. 2017;60(3):1159-1170. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01607","DOI":"10.1021\/acs.jmedchem.6b01607"},{"key":"9588_CR61","doi-asserted-by":"publisher","unstructured":"Carta F, Di Cesare Mannelli L, Pinard M, Ghelardini C, Scozzafava A, McKenna R et al. A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects. Bioorg Med Chem. 2015;23(8):1828-40. https:\/\/doi.org\/10.1016\/j.bmc.2015.02.027","DOI":"10.1016\/j.bmc.2015.02.027"},{"key":"9588_CR62","doi-asserted-by":"publisher","unstructured":"Supuran CT. Drug interactions of carbonic anhydrase inhibitors and activators. Expert Opin Drug Metab Toxicol. 2024;20(3):143-155. https:\/\/doi.org\/10.1080\/17425255.2024.2328152","DOI":"10.1080\/17425255.2024.2328152"},{"key":"9588_CR63","doi-asserted-by":"publisher","unstructured":"Dermitzakis I, Manthou ME, Meditskou S, Miliaras D, Kesidou E, Boziki M et al. Developmental Cues and Molecular Drivers in Myelinogenesis: Revisiting Early Life to Re-Evaluate the Integrity of CNS Myelin.Curr Issues Mol Biol. 2022;44(7):3208-3237. https:\/\/doi.org\/10.3390\/cimb44070222","DOI":"10.3390\/cimb44070222"},{"key":"9588_CR64","doi-asserted-by":"publisher","unstructured":"Beirowski B, Gustin J, Armour SM, Yamamoto H, Viader A, North BJ et al. Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3\/atypical protein kinase C (aPKC) signaling. Proc Natl Acad Sci U S A. 2011;108(43):E952-61. https:\/\/doi.org\/10.1073\/pnas.1104969108","DOI":"10.1073\/pnas.1104969108"},{"key":"9588_CR65","doi-asserted-by":"publisher","unstructured":"Roussel-Gervais A, Sgroi S, Cambet Y, Lemeille S, Seredenina T, Krause KH et al. Genetic knockout of NTRK2 by CRISPR\/Cas9 decreases neurogenesis and favors glial progenitors during differentiation of neural progenitor stem cells.Front Cell Neurosci. 2023;17:1289966. https:\/\/doi.org\/10.3389\/fncel.2023.1289966","DOI":"10.3389\/fncel.2023.1289966"},{"key":"9588_CR66","doi-asserted-by":"publisher","first-page":"26357","DOI":"10.1074\/jbc.M112.446138","volume":"288","author":"HS Kwon","year":"2013","unstructured":"Kwon HS, Johnson TV, Joe MK, Abu-Asab M, Zhang J, Chan CC, et al. Myocilin mediates myelination in the peripheral nervous system through ErbB2\/3 signaling. J Biol Chem. 2013;288(37):26357-71. https:\/\/doi.org\/10.1074\/jbc.M112.446138","journal-title":"J Biol Chem [Internet]"},{"key":"9588_CR67","doi-asserted-by":"publisher","unstructured":"Balakrishnan A, Belfiore L, Chu TH, Fleming T, Midha R, Biernaskie J et al. Insights Into the Role and Potential of Schwann Cells for Peripheral Nerve Repair From Studies of Development and Injury. Front Mol Neurosci. 2021;13:608442. https:\/\/doi.org\/10.3389\/fnmol.2020.608442","DOI":"10.3389\/fnmol.2020.608442"},{"key":"9588_CR68","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.nbd.2013.03.005","volume":"55","author":"E Ydens","year":"2013","unstructured":"Ydens E, Lornet G, Smits V, Goethals S, Timmerman V, Janssens S. The neuroinflammatory role of Schwann cells in disease. Neurobiol Dis. 2013;55:95\u2013103. https:\/\/doi.org\/10.1016\/j.nbd.2013.03.005","journal-title":"Neurobiol Dis"},{"key":"9588_CR69","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/mus.27496","volume":"65","author":"AN \u00d6zda\u011f Acarl\u0131","year":"2022","unstructured":"\u00d6zda\u011f Acarl\u0131 AN, Klein T, Egenolf N, Sommer C, \u00dc\u00e7eyler N. Subepidermal Schwann cell counts correlate with skin innervation \u2013 an exploratory study. Muscle Nerve. 2022;65:471\u20139. https:\/\/doi.org\/10.1002\/mus.27496","journal-title":"Muscle Nerve"},{"key":"9588_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00116","volume":"13","author":"Z Wei","year":"2019","unstructured":"Wei Z, Fei Y, Su W, Chen G. Emerging role of schwann cells in neuropathic pain: receptors, glial mediators and myelination. Front Cell Neurosci. 2019;13:445946. https:\/\/doi.org\/10.3389\/fncel.2019.00116.","journal-title":"Front Cell Neurosci"},{"key":"9588_CR71","doi-asserted-by":"publisher","unstructured":"Wang Q, Chen FY, Ling ZM, Su WF, Zhao YY, Chen G, et al. The effect of Schwann cells\/Schwann cell-like cells on cell therapy for peripheral neuropathy. Front Cell Neurosci. 2022;16:836931. 4https:\/\/doi.org\/10.3389\/fncel.2022.836931","DOI":"10.3389\/fncel.2022.836931"},{"key":"9588_CR72","doi-asserted-by":"publisher","unstructured":"Igharo D, Thiel JC, Rolke R, Akkaya M, Weis J, Katona I et al. Skin biopsy reveals generalized small fibre neuropathy in hypermobile Ehlers\u2013Danlos syndromes. Eur J Neurol. 2023;30(3):719-728. https:\/\/doi.org\/10.1111\/ene.15649","DOI":"10.1111\/ene.15649"},{"key":"9588_CR73","doi-asserted-by":"publisher","unstructured":"Cazzato D, Castori M, Lombardi R, Caravello F, Bella ED, Petrucci A et al. Small fiber neuropathy is a common feature of Ehlers-Danlos syndromes. Neurology. 2016;87(2):155-9. https:\/\/doi.org\/10.1212\/WNL.0000000000002847","DOI":"10.1212\/WNL.0000000000002847"},{"key":"9588_CR74","doi-asserted-by":"publisher","unstructured":"Leone CM, Celletti C, Gaudiano G, Puglisi PA, Fasolino A, Cruccu G et al. Pain due to ehlers-danlos syndrome is associated with deficit of the endogenous pain inhibitory control. Pain Med. 2020;21(9):1929-1935. https:\/\/doi.org\/10.1093\/pm\/pnaa038","DOI":"10.1093\/pm\/pnaa038"},{"key":"9588_CR75","doi-asserted-by":"publisher","unstructured":"Pascarella A, Provitera V, Lullo F, Stancanelli A, Saltalamacchia AM, Caporaso G et al. Evidence of small fiber neuropathy in a patient with Ehlers\u2013Danlos syndrome, hypermobility-type. Clin Neurophysiol. 2016;127(3):1914-6. https:\/\/doi.org\/10.1016\/j.clinph.2015.12.004","DOI":"10.1016\/j.clinph.2015.12.004"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12014-026-09588-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-026-09588-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-026-09588-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:16:21Z","timestamp":1776168981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12014-026-09588-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["9588"],"URL":"https:\/\/doi.org\/10.1186\/s12014-026-09588-2","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local Ethical Committee \u201cComitato Etico di Brescia, ASST degli Spedali Civili, Brescia\u201d in Italy (Protocol numbers NP5582) and by the \u201cGenetic Alliance Institutional Review Board\u201d in the USA (Federal Registration Number IORG0003358, Project number EDS002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All subjects provided written informed consent for their inclusion in the study and for the use of their clinical data and samples for research purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}